Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Entera Bio (ENTX) Interest & Investment Income (2018 - 2021)

Entera Bio has reported Interest & Investment Income over the past 4 years, most recently at -$677000.0 for Q3 2021.

  • For the quarter ending Q3 2021, Interest & Investment Income rose 14.52% year-over-year to -$677000.0, compared with a TTM value of -$1.8 million through Sep 2021, down 53.57%, and an annual FY2019 reading of -$659000.0, down 18.31% over the prior year.
  • Interest & Investment Income came in at -$677000.0 for Q3 2021, up from -$792000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $2.2 million in Q3 2018 to a low of -$2.9 million in Q2 2018.
  • Median Interest & Investment Income over the past 4 years was -$96000.0 (2019), compared with a mean of -$272636.4.
  • The largest YoY upside for Interest & Investment Income was 123.96% in 2020 against a maximum downside of 610.97% in 2020.
  • Over 4 years, Interest & Investment Income stood at $162000.0 in 2018, then crashed by 133.95% to -$55000.0 in 2019, then crashed by 1340.0% to -$792000.0 in 2020, then grew by 14.52% to -$677000.0 in 2021.
  • Per Business Quant, the three most recent readings for ENTX's Interest & Investment Income are -$677000.0 (Q3 2021), -$792000.0 (Q3 2020), and -$337000.0 (Q2 2020).